Intraperitoneal immunotherapy of cancer: a review of options for treatment.
van Ravenswaay Claasen
H H
HH
Department of Pathology, University of Leiden, Netherlands.
Eggermont
A M
AM
D019264:Adoptive Transfer; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D007372:Interferons / Q000627:therapeutic use; D007376:Interleukin-2 / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*; D016499:Radioimmunotherapy
D000911:Antibodies, Monoclonal; D007376:Interleukin-2; D007372:Interferons